Republic Healthcare Limited provided unaudited consolidated earnings guidance for the three months ended 31 March 2022. For the period, the company expects to inform the shareholders of the company and potential investors that, based on the preliminary assessment by the Board on the unaudited consolidated management accounts of the Group for the three months ended 31 March 2022 and the information currently available to the Board, the Group is expected to record a net loss of approximately SGD 700,000 for the three months ended 31 March 2022 as compared to the net profit for the three months ended 31 March 2021 of SGD 228.